Literature DB >> 2570211

Intrathecal baclofen for intractable spasticity due to severe brain injury.

L Saltuari, E Schmutzhard, M Kofler, H Baumgartner, F Aichner, F Gerstenbrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2570211     DOI： 10.1016/s0140-6736(89)92114-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

Authors:  C de Champs; D Guelon; D Joyon; D Sirot; M Chanal; J Sirot
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

2.  Management of intrathecal baclofen therapy for severe acquired brain injury: consensus and recommendations for good clinical practice.

Authors:  Antonio De Tanti; Federico Scarponi; Michele Bertoni; Giulio Gasperini; Bernardo Lanzillo; Franco Molteni; Federico Posteraro; Dino Francesco Vitale; Mauro Zanpolini
Journal:  Neurol Sci       Date:  2017-05-06       Impact factor: 3.307

3.  The child with cerebral palsy--clinical considerations and management.

Authors:  P Singhi
Journal:  Indian J Pediatr       Date:  2001-06       Impact factor: 1.967

4.  On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity-An observational study.

Authors:  Lucas-Michael Halbmayer; Markus Kofler; Gabriel Hitzenberger; Heinrich Matzak; Elena Fava; Eleonora Genelin; Mario Werkmann; Leopold Saltuari; Viviana Versace; Judith Dobesberger; Elke Pucks-Faes
Journal:  Brain Behav       Date:  2022-04-10       Impact factor: 3.405
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.